#Eye Issues May Linger for Long-Term #Dupilumab Users With #Atopic #Dermatitis. www.medscape.com/vie...

Patients with moderate-to-severe #AtopicDermatitis treated with #Dupilumab may have elevated risk of developing ocular adverse effects, particularly those affecting the ocular surface, according to research published in Clinical Science.

Learn more: https://bit.ly/47BRIGJ

Underweight children with #atopic #dermatitis who received #dupilumab saw significant gains in body weight and BMI at 16 weeks compared with placebo, with the greatest gains observed among children aged 2 to 5 years. www.healio.com/news/...

A 12-month course of #dupilumab improves #otologic and #sinonasal #outcomes in adults with severe #nasal #polyps and #eosinophilic #otitis media, but experts differ on when to start a #biologic. www.medscape.com/vie...

#Dupilumab therapy in pediatric patients with moderate to severe #AtopicDermatitis is associated with meaningful increases in weight & #BMI. #EADV2026

https://www.dermatologyadvisor.com/reports/dupilumab-pediatric-ad-associated-with-weight-bmi-increases/

#Oral #Food #Challenge #Reactions Appear More Common With #Dupilumab Despite Lower #Food-#Specific #IgE Levels www.medscape.com/vie...

#Dupilumab was associated with histologic #remission and improvements in endoscopic parameters among #children and #adolescents with #eosinophilic #oesophagitis who had predominantly not responded to standard treatments. www.medscape.com/vie...

From @accpchest.bsky.social 🫁

#Dupilumab was not associated with a significantly increased risk for #lymphoma when compared with other biologics in patients with severe #asthma, though further studies with longer follow-up periods are warranted. #PulmSky #OncSky

1) Recomendado: #Dupilumab #Salud #Medicina

The odds for #clinical #remission achievement in patients with #type2 #inflammatory #severe #asthma were greater with #dupilumab vs. other #biologics, according to a poster presented at the #ERS Congress. www.healio.com/news/...